7 hours Ago By Defense World Staff
Russell Investments Group Ltd. cut its holdings in Inogen, Inc. (NASDAQ:INGN – Free Report) by 10.
9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,048 shares of the medical technology company’s stock after selling 1,723 shares during the period. Russell Investments Group Ltd.
owned about 0.06% of Inogen worth $129,000 at the end of the most recent reporting period. Several other hedge funds have also recently made changes to their positions in INGN.
AlphaQuest LLC purchased a new stake in Inogen during the fourth quarter valued at approximately $43,000. Meeder Asset Management Inc. purchased a new stake in Inogen during the 4th quarter valued at $56,000.
Integrated Quantitative Investments LLC bought a new stake in Inogen in the fourth quarter worth $92,000. Intech Investment Management LLC purchased a new position in Inogen during the fourth quarter worth $94,000. Finally, Ieq Capital LLC bought a new position in Inogen during the fourth quarter valued at $94,000.
89.94% of the stock is currently owned by hedge funds and other institutional investors. Inogen Trading Up 1.
8 %NASDAQ INGN opened at $7.28 on Friday. Inogen, Inc.
has a 12 month low of $6.40 and a 12 month high of $13.33.
The company’s 50-day moving average price is $7.59 and its 200-day moving average price is $9.06.
The stock has a market cap of $195.74 million, a PE ratio of -3.24 and a beta of 1.
48. Analyst Upgrades and DowngradesA number of equities analysts recently commented on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Inogen in a research note on Wednesday, April 9th.
StockNews.com cut Inogen from a “buy” rating to a “hold” rating in a research note on Wednesday, February 26th.Get Our Latest Stock Analysis on INGNAbout Inogen (Free Report)Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally.
Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.Further ReadingFive stocks we like better than InogenWhat is a Bond Market Holiday? How to Invest and TradeShort Sellers Gave Up on These 3 Names RecentlyHigh Dividend REITs: Are They an Ideal Way to Diversify?3 Boring Stocks Outperforming the Market This YearBest ESG Stocks: 11 Best Stocks for ESG InvestingIf You Wanted To Buy AbbVie and Didn’t, There’s Still Time To BuyWant to see what other hedge funds are holding INGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inogen, Inc.
(NASDAQ:INGN – Free Report)..
